- More than 5,000 generic and trade-name drugs are profiled, covering almost every drug you will administer in practice or in clinicals. - Safety Alert icon highlights the most critical drug interactions and side effects. - Black Box Warnings provide alerts to FDA warnings of dangerous or life-threatening drug reactions. - Nursing Process steps are used as the framework for organizing all nursing care information. - Coverage of IV drug administration highlights dosage and IV administration instructions, including safety considerations and Y-site, syringe, and additive compatibilities. - Side effects information is organized by body system and identified as common or life threatening, showing signs to watch for during assessments. - Alphabetical organization by generic name provides quick and easy access to specific drugs, and a full-color design highlights important information. - Complete pharmacokinetic information includes the mechanism and absorption of the drug as well as its action, duration, and excretion. - Overview of drug categories explains the safe administration of common classes of drugs, as well as their common side effects and interactions. - Flexible, water-resistant cover provides durability in the clinical setting. - NEW! Drug monographs for 35 new FDA-approved medications equip you with the latest drug information including generic names, trade names, pronunciations, do-not-confuse drugs, action, uses, contraindications, precautions, dosages and routes, side effects, pharmacokinetics, interactions (including drug/herb, drug/food and drug/lab test), nursing considerations, treatment of overdose, patient/family teaching, and more. - NEW! Updates on drug therapies provide the most current information.
Table of Contents
INDIVIDUAL DRUG MONOGRAPHSAPPENDIXES
A. Selected New Drugs
abametapir
aducanumab-avwa
afamelanotide
anifrolumab-fnia
asciminib
atogepant
avacopan
avapritinib
belumosudil
belzutifan
bempedoic acid
brolucizumab-dbll
difelikefalin
dostarlimab-gxly
eculizumab
efavirenz/emtricitabine/tenofovir
elapegademase-ivir
elbasvir/grazoprevir
elexacaftor/tezacaftor/ivacaftor and ivacaftor
emtricitabine/rilpivirine/tenofovir alafenamide
enalapril/hydrochlorothiazide
ephedrine
factor IX complex
factor IX, human
factor IX, recombinant
finerenone
fluocinolone
fluocinonide
lonapegsomatropin-tcgd
loncastuximab tesirine-lpyl
maribavir
mobocertinib
odevixibat
ropeginterferon alfa-2b
tisotumab vedotin-tftv
vosoritide
B. Ophthalmic, Nasal, Topical, and Otic Products
C. Vaccines and Toxoids
D. Recent FDA Drug Approvals
INDEX
EVOLVE WEBSITE
. Additional Monographs
. Drug Categories